Orthopediatrics (KIDS) Getting Somewhat Positive Press Coverage, Report Finds
News coverage about Orthopediatrics (NASDAQ:KIDS) has been trending somewhat positive on Saturday, according to Accern. The research firm identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Orthopediatrics earned a daily sentiment score of 0.03 on Accern’s scale. Accern also assigned headlines about the company an impact score of 45.9306344122718 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Here are some of the headlines that may have effected Accern Sentiment’s rankings:
- Orthopediatrics’ (KIDS) Buy Rating Reaffirmed at BTIG Research (americanbankingnews.com)
- OrthoPediatrics Corp. Announces Preliminary Revenue for Fourth Quarter and Full Year 2017 (finance.yahoo.com)
- OrthoPediatrics Corp. Expands PediPlates® Franchise with Titanium System (finance.yahoo.com)
- Analysts Set $23.67 Target Price for Orthopediatrics Corp (KIDS) (americanbankingnews.com)
- St Jude Medical (STJ) & Orthopediatrics (KIDS) Financial Comparison (americanbankingnews.com)
Shares of Orthopediatrics (NASDAQ KIDS) traded up $0.51 during trading on Friday, reaching $20.05. 58,861 shares of the company’s stock were exchanged, compared to its average volume of 65,055. The company has a debt-to-equity ratio of -0.38, a current ratio of 2.78 and a quick ratio of 1.00. Orthopediatrics has a twelve month low of $17.03 and a twelve month high of $23.00. The firm has a market cap of $261.24 and a price-to-earnings ratio of 20.89.
A number of research analysts have issued reports on the stock. BTIG Research restated a “buy” rating and set a $24.00 price target on shares of Orthopediatrics in a research note on Friday. Stifel Nicolaus assumed coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They set a “buy” rating and a $23.00 price target on the stock. William Blair assumed coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They set an “outperform” rating on the stock. Finally, Piper Jaffray Companies assumed coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They set an “overweight” rating and a $24.00 price target on the stock.
In related news, Director Harold Ruf purchased 11,500 shares of the business’s stock in a transaction on Monday, October 16th. The shares were acquired at an average price of $13.00 per share, for a total transaction of $149,500.00. The transaction was disclosed in a filing with the SEC, which is available at this link.
COPYRIGHT VIOLATION NOTICE: “Orthopediatrics (KIDS) Getting Somewhat Positive Press Coverage, Report Finds” was originally reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://www.watchlistnews.com/orthopediatrics-kids-getting-somewhat-positive-press-coverage-report-finds/1797601.html.
OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with Analyst Ratings Network's FREE daily email newsletter.